Cargando…
Validation of CPS+EG, Neo‐Bioscore, and modified Neo‐Bioscore staging systems after preoperative systemic therapy of breast cancer: Protocol of a retrospective multicenter cohort study in China
Prognostic assessment after preoperative systemic therapy (PST) is critical to develop a therapeutic strategy for breast cancer management. Currently, a clinical–pathologic staging system that incorporates ER status and nuclear grading (CPS + EG), and the Neo‐Bioscore system that includes HER2 statu...
Autores principales: | Xu, Ling, Zhang, Zhuo, Liu, Qianxin, Zhou, Bin, Liu, Yinhua, Xiang, Qian, Zhu, Sainan, Duan, Xuening, Cui, Yimin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6209787/ https://www.ncbi.nlm.nih.gov/pubmed/30296013 http://dx.doi.org/10.1111/1759-7714.12852 |
Ejemplares similares
-
Assessment of CPS + EG, Neo-Bioscore and Modified Neo-Bioscore in Breast Cancer Patients Treated With Preoperative Systemic Therapy: A Multicenter Cohort Study
por: Xu, Ling, et al.
Publicado: (2021) -
External verification and improvement of the Neo-Bioscore staging system in a Chinese cohort
por: Geng, Rui, et al.
Publicado: (2022) -
Determination of breast cancer prognosis after neoadjuvant chemotherapy: comparison of Residual Cancer Burden (RCB) and Neo-Bioscore
por: Laas, Enora, et al.
Publicado: (2021) -
Evaluation of the relationship between Ki67 expression level and neoadjuvant treatment response and prognosis in breast cancer based on the Neo-Bioscore staging system
por: Sullu, Yurdanur, et al.
Publicado: (2023) -
Development of Prediction Models for New Integrated Models and a Bioscore System to Identify Bacterial Infections in Systemic Lupus Erythematosus
por: Zhai, Xvwen, et al.
Publicado: (2021)